Studies have discovered that the point mutations in the SERPINA1 gene, which cause gain of function, lead to cirrhosis, whereas gain of function mutations causes pulmonary emphysema, a clinical condition comprising COPD [23, 24]. Here, SERPINA1 is linked to pulmonary emphysema.